Latest Rhinitis Stories
Doctors from Italy are saying that pollen seasons may be longer due to changes in climate patterns, causing an extended period of congestion and sneezing for people with allergies, especially hay fever.
AUSTIN, Texas, Feb. 13 /PRNewswire/ -- The beauty of budding plants and bouquet of aromas are sources of satisfaction for many gardeners.
Medication Delivered Under the Tongue May Be Alternative to Allergy Shots PITTSBURGH, Feb.
OXFORD, England, February 12 /PRNewswire/ -- Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that its ToleroMune(R) ragweed allergy T-cell vaccine achieved positive results in a recently completed phase II clinical trial.
Eczema in early childhood may influence behavior and mental health later in life.
Exposing patients with chronic sinus disease to allergens and then obtaining repeated images by X-ray or ultrasound reveals that nasal allergies may be involved in some cases of chronic sinus disease.
PARIS, December 7 /PRNewswire-FirstCall/ -- - Very Positive 3-Year Results of the Long-Term Study Provide Confirmation of the Clinical Relevance of Oralair(R) Stallergenes S.A.
OptiNose is pleased to announce the publication of results from its Phase II clinical study investigating the efficacy and tolerability of its novel, intranasal drug/device product for the topical treatment of chronic rhinosinusitis with nasal polyps in Rhinology, the official journal of the International and European Rhinologic Societies.
LINCOLN, R.I., Dec. 1 /PRNewswire/ -- QualityMetric Incorporated and Pollen.com, the most visited allergy site on the web, announce the availability of the Rhinitis Impact(TM) Survey.
PARIS, November 27 /PRNewswire-FirstCall/ -- Stallergenes has been granted European approval to market Oralair(R) in both adults and children through a Mutual Recognition Procedure.